https://specialty.mims.com/topic/glp-1-receptor-agonists-halt-copd-exacerbations-in-t2d-patients
Use of glucagon-like peptide 1 (GLP-1) receptor agonists or sodium-glucose co-transporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, helps pr...
Create an account or login to join the discussion